RxDoctor Payments Data

Ashley Darago

Family · Princeton, WVNPI 1750834644

Payments from drug & device makers

$1,980in general payments, 2019–2025

Across 117 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$493
  • Lilly USA, LLC$340
  • Boehringer Ingelheim$254
  • AbbVie$241
  • GSK$225
  • Exact Sciences$129
  • plus $299 from 10 others

What the payments were for

  • Food & beverage$1,96999%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,980 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$91,016
MounjaroTirzepatide60$66,548
JardianceEmpagliflozin55$47,679
FarxigaDapagliflozin Propanediol40$37,669
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$31,760
EliquisApixaban20$17,460
JanuviaSitagliptin Phosphate21$17,223
RybelsusSemaglutide11$15,652
KerendiaFinerenone24$13,999
Tresiba Flextouch U-200Insulin Degludec14$12,748
MyrbetriqMirabegron13$8,727
HumalogInsulin Lispro11$6,047
SymbicortBudesonide/Formoterol Fumarate21$5,166
NexletolBempedoic Acid11$5,005
Albuterol Sulfate HfaAlbuterol Sulfate105$3,126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$493$106,668101 claims
Lilly USA, LLCMounjaro, Humalog$340$72,59471 claims
Boehringer IngelheimJardiance$254$47,67955 claims
AstraZenecaFarxiga, Symbicort$58$42,83561 claims
GSKTrelegy Ellipta$225$31,76044 claims
PfizerEliquis$33$17,46020 claims
MerckJanuvia$15$17,22321 claims
BayerKerendia$16$13,99924 claims
AbbVieSynthroid$241$1,06111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,507 family providers in West Virginia.

Other family in Princeton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →